Results 121 to 130 of about 1,366 (166)

The Neuronal ALAS2/5-Ala Axis Mitigates Chemotherapy-Induced Neurotoxicity via the BACH1/NRF2 Pathway

British Journal of Pharmacology
Despite breakthroughs in immunotherapy and targeted therapies, chemotherapy remains indispensable in oncology.
Jing Chen, Hai-Yan Wu
exaly   +4 more sources

Protective Effects of Electroacupuncture on Polycystic Ovary Syndrome in Rats: Down-Regulating Alas2 to Inhibit Apoptosis, Oxidative Stress, and Mitochondrial Dysfunction in Ovarian Granulosa Cells

Tissue and Cell, 2023
Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder affecting women at reproductive age. The therapeutic effect of electroacupuncture (EA) on PCOS has been revealed, while the anti-PCOS mechanisms of EA have not been fully explored. In
Jing Cong, Jingshu Gao, Hongli Ma
exaly   +2 more sources

Rapid Detection of Blood Using a Novel Application of RT-RPA Integrated With CRISPR-Cas: ALAS2 Detection as a Model

Forensic Science International: Genetics
A rapid, sensitive and specific test for blood is reported based on a novel application of recombinase polymerase amplification integrated with CRISPR-Cas and lateral flow assay (LFA).
Adrian Linacre   +2 more
exaly   +2 more sources

Uncoupling Alas2 from Iron-Regulatory Proteins Demonstrates the Protective Role of Alas2 Iron-Responsive Element in Protoporphyrias

Blood
Introduction. Many genes relevant to iron metabolism include a transcribed cis-regulatory element called iron-responsive element (IRE) that couples their expression to the availability of intracellular iron. Canonical IREs consist of a conserved stem-
Sarah Ducamp   +3 more
semanticscholar   +2 more sources

A synonymous coding variant that alters ALAS2 splicing and causes X‐linked sideroblastic anemia

Pediatric Blood & Cancer, 2021
To the Editor: X-linkedsideroblastic anemia (XLSA) is the most common form of congenital sideroblastic anemia (CSA). Approximately 70 different mutations have been described.
Jamie Oakley   +7 more
semanticscholar   +3 more sources

X-linked Dominant Erythropoietic Protoporphyria with early-onset manifestations caused by a hemizygous ALAS2 variant.

Clinical and Experimental Dermatology
Erythropoietic protoporphyria (EPP) is usually caused by autosomal dominant mutations in the ferrochelatase gene (FECH), blocking the conversion of protoporphyrin to haem.
S. Srinivas, C. Moss
semanticscholar   +3 more sources

miR-218 Inhibits Erythroid Differentiation and Alters Iron Metabolism by Targeting ALAS2 in K562 Cells

open access: yesInternational Journal of Molecular Sciences, 2015
microRNAs (miRNAs) are involved in a variety of biological processes. The regulatory function and potential role of miRNAs targeting the mRNA of the 5′-aminolevulinate synthase 2 (ALAS2) in erythropoiesis were investigated in order to identify miRNAs ...
Hongzhu Qu, Yanming Li, Hongying Sun
exaly   +2 more sources

R411C Mutation of the ALAS2 Gene Encodes a Pyridoxine-Responsive Enzyme With Low Activity [PDF]

open access: yesBritish Journal of Haematology, 1998
A R411C missense mutation of the erythroid‐specific δ‐aminolaevulinate synthase (ALAS2) gene was identified in a pedigree with X‐linked pyridoxine‐responsive sideroblastic anaemia (XLSA). The normal and the mutant cDNAs were expressed in E. coli, and the enzyme protein was purified.
Kazumichi Furuyama   +2 more
exaly   +4 more sources

Characterization of zebrafish alas2 reporter for study on erythropoiesis, blood flow and erythroid disease.

Journal of Genetics and Genomics
Wenjuan Zhang   +8 more
semanticscholar   +3 more sources

Home - About - Disclaimer - Privacy